Otsuka Pharma obtains registration in Japan for new pro patch”, for percutaneous application of a dopamine receptor agonist “ Dec 25, 2012 Indications are Parkinson’s disease and idiopathic restless legs syndrome Otsuka Pharma press release, Dec. 25, 2012